Navigation Links
The 3rd Annual Burrill Personalized Medicine Meeting November 12-13, 2007 in San Francisco
Date:9/13/2007

Leading thinkers and senior executives from companies and government

organizations will gather for 3rd Annual Personalized Medicine event

produced by Burrill Life Sciences Media Group

SAN FRANCISCO, Sept. 13 /PRNewswire/ -- In the foreseeable future a trip to the doctor's office will be a radically different experience to what it is today. Armed with our complete genetic profile information about predisposition to disease, the appropriate remedial therapies, even what foods to eat will be part of the doctor's advice. While we can see the future of health care, we are still a tantalizing long way away from embracing it. There are many scientific, legal, ethical, regulatory and policy challenges that have to be addressed before personalized medicine becomes a reality in 21st century medicine.

The 3rd Burrill Personalized Medicine Meeting (San Francisco, November 12-13, 2007), hosted by Burrill Life Sciences Media Group, a joint venture of Nielsen Business Media and Burrill & Company, provides a "window" into these new realities with detailed discussions and analysis on the whole spectrum of personalized medicine -- from prediction to prevention and how they will have a major impact on the delivery of health care.

Some of the leading thinkers and senior executives from companies and government organizations will be participating in this event. Sessions include:

-- Personalized Medicine in the Clinic

-- How Science and Technology is Accelerating the Pace of Biomarker

Development

-- Targeted Treatments vs. The "one size fits all" Blockbuster

-- Pharmacogenomics comes of Age

-- The increasing role of Diagnostics in Personalized Medicine

-- Patient-centric Medicine -- Personalized Medicine from the Patient's

Point of View

-- The Regulatory Environment: The FDA's Perspective

The Burrill Personalized Medicine Meeting has established itself as a "must attend" event that not only embraces the current state of personalized medicine but also the business, finance, regulatory and reimbursement issues that are linked with this rapidly evolving field. It provides a forum for education, discussion and networking with the leaders in this field.

About Burrill Life Sciences Media Group

The Burrill Life Sciences Media Group, a joint venture of Burrill & Company and Nielsen Business Media, produces worldwide life sciences conferences, and leading publications including an annual book on the "State of the Industry, the 21st Edition is Biotech 2007: Life Sciences-A Global Transformation; a series of bio-intelligence reports including the Personalized Medicine Report, and The Journal of Life Sciences, in association with the California Healthcare Institute.

For further information:

Website: http://www.personalizedmedicinemeeting.com


'/>"/>
SOURCE Burrill Life Sciences Media Group
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. NameProtect releases annual list of top trademarkers
2. Doyle says new contracts saving state more than $16 million annually
3. Department of Commerce offers up to $1 million annually to aid tech entrepreneurs
4. Annual Bioethics Forum to explore genetic testing
5. Annual Conference Honors Tech Grant Winners
6. Winner of Burrill competition courted by North Carolina investors
7. Technology and business merge at UW Burrill Competition
8. Romanian Student Leverages Burrill Competition to Accomplish Her Dream
9. Romanian Student Leverages Burrill Competition to Accomplish Her Dream
10. Students Win Burrill Competition With Plan for Renewable Energy
11. Romanian Student Leverages Burrill Competition to Accomplish Her Dream
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 8, 2016 Eutilex Co. Ltd. today announced ... $18.9M) Series A financing. This financing round included participation ... and SNU Bio Angel. This new funding brings the ... (US $27.7M) since its founding in 2015. ... development and commercialization of its immuno-oncology programs, expand its ...
(Date:12/7/2016)... ... December 07, 2016 , ... ACEA ... dose escalation and expansion clinical trial for its lead drug candidate, AC0010, at ... of the trial was to determine the safety, antitumor activity, and recommended phase ...
(Date:12/7/2016)... LANSING, Mich. , Dec. 7, 2016 ... it has named Dr. Dan Kephart as ... the company. Kephart will assume his responsibilities at Neogen ... research and development director for the agribusiness unit of ... food safety development at Life Technologies. His extensive industry ...
(Date:12/7/2016)... 2016  Nordion, a standalone business of Sterigenics ... today,s award by the United States Department of ... the Phase II cooperative agreement funding to GA ... University of Missouri Research Reactor Center (MURR ® ... establishment of a new, reliable supply of molybdenum ...
Breaking Biology Technology:
(Date:11/22/2016)... , November 22, 2016 According to the new ... Palm Print, Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function ... by MarketsandMarkets, the market is expected to grow from USD 10.74 Billion ... of 16.79% between 2016 and 2022. Continue ... ...
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is to ... for Private Biobanks shows the highest Compounded Annual Growth Rate ... region during the analysis period 2014-2020. North ... of 9.95% followed by Europe at ...
(Date:11/15/2016)... Research and Markets has announced the addition of the "Bioinformatics ... ... The global bioinformatics market is projected ... in 2016, growing at a CAGR of 21.1% during the forecast ... by the growing demand for nucleic acid and protein sequencing, increasing ...
Breaking Biology News(10 mins):